Teva has received approval to market in Europe: Ajovy a treatment for migraine

Posted on Apr 2, 2019 by Ifi Reporter

Teva has received approval from the European Council to market Ajovy, a migraine-prevention shot in adults with at least four migraine days a month. Agovy is a CGRP blocker, a neurotransmitter responsible for transmitting messages in different parts of the body and involved in the biological processes that cause migraine.
Agovi of Teva competes with two other drugs from this family: Aimovig of Amgen and Emgality of Eli Lilly. Teva's drug is the only one approved and given once a quarter and once a month.
The European Council's decision is valid for all 28 EU member states, in addition to Iceland, Norway and Liechtenstein. Migraine drugs are designed to treat 50 million patients in EU countries.
Teva received approval to market Ajobi in the United States in September 2018, and holds 19% of the prescription for migraine drugs and 30% of the prescriptions for new patients Teva estimates that Agobe's US sales will grow from $ 6 million in 2018 To $ 150 million in 2019.


Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum


Strong US Employment Report Boosts Dollar Against Major Currencies

Dec 8, 2023 by Ifi Reporter

In the wake of a robust employment report from the United States, the dollar remains stable against the Israeli shekel at NIS 3.70. The positive data, which surpassed expectations, has notably strengthened the American currency against the euro and the pound. As of the latest market... Continue reading →

Maersk Implements "War Levy" on Container Shipments to Israel Amidst Security Concerns

Dec 8, 2023 by Ifi Reporter

In response to escalating security risks in the region, Danish shipping giant Maersk has announced the imposition of a "war levy" on container shipments to Israel. Citing a surge in insurance premiums for vessels arriving in Israel, Maersk stated that the emergency risk supplement is... Continue reading →

Isrotel is making significant strides in its international expansion efforts

Dec 7, 2023 by Ifi Reporter

Isrotel, the prominent Israeli hotel chain under the Lewis family's control and managed by Lior Raviv, is making significant strides in its international expansion efforts. The company has successfully acquired 50% ownership in three hotels in Athens, including one with two separate wings,... Continue reading →


No testimonials. Click here to add your testimonials.